Glucose metabolism in mice lacking muscle glycogen synthase

Diabetes

Volumn 54, Issue 12, 2005, Pages 3466-3473

  Pederson, Bartholomew A ^a   Schroeder, Jill M ^a   Parker, Gretchen E ^a   Smith, Micah W ^a   DePaoli Roach, Anna A ^a   Roach, Peter J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; GLYCOGEN MUSCLE LEVEL; INSULIN BLOOD LEVEL; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; DIETARY FATS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOGEN SYNTHASE; GROWTH; INSULIN; LIVER GLYCOGEN; MALE; MICE; MICE, KNOCKOUT; MUSCLE FIBERS; MUSCLE, SKELETAL;

EID: 33644698545     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3466     Document Type: Article

References (52)

1. Preiss J, Walsh DA: The comparative biochemistry of glycogen and starch. In Biology of Carbohydrates. Ginsburg V, Robbins P, Eds. New York, John Wiley, 1981, p. 199-314
2. Kaslow HR, Lesikar DD, Antwi D, Tan AW: L-type glycogen synthase: tissue distribution and electrophoretic mobility. J Biol Chem 260:9953-9956, 1985
3. Kaslow HR, Lesikar DD: Isozymes of glycogen synthase. FEBS Lett 172:294-298, 1984
4. Meyer C, Dostou JM, Welle SL, Gerich JE: Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab 282:E419-E427, 2002
5. Jue T, Rothman DL, Shulman GI, Tavitian BA, DeFronzo RA, Shulman RG: Direct observation of glycogen synthesis in human muscle with 13C NMR. Proc Natl Acad Sci U S A 86:4489-4491, 1989
6. Orho-Melander M, Shimomura H, Sanke T, Rasmussen SK, Nanjo K, Pedersen O, Groop LC: Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes 48:918-920, 1999
7. Pederson BA, Chen H, Schroeder JM, Shou W, DePaoli-Roach AA, Roach PJ: Abnormal cardiac development in the absence of heart glycogen. Mol Cell Biol 24:7179-7187, 2004
8. Suzuki Y, Lanner C, Kim JH, Vilardo PG, Zhang H, Yang J, Cooper LD, Steele M, Kennedy A, Bock CB, Scrimgeour A, Lawrence JC Jr, DePaoli-Roach AA: Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Mol Cell Bio 21:2683-2694, 2001
9. Thomas JA, Schlender KK, Larner J: A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25:486-499, 1968
10. Guth L, Samaha FJ: Procedure for the histochemical demonstration of actomyosin ATPase. Exp Neurol 28:365-367, 1970
11. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, Benito M: Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108:1205-1213, 2001
12. Halseth AE, Bracy DP, Wasserman DH: Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo. Am J Physiol 276:E70-E77, 1999
13. Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362, 1985
14. Tamashiro KL, Wakayama T, Akutsu H, Yamazaki Y, Lachey JL, Wortman MD, Seeley RJ, D'Alessio DA, Woods SC, Yanagimachi R, Sakai RR: Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med 8:262-267, 2002
15. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
16. Pederson BA, Cope CR, Schroeder JM, Smith MW, Irimia JM, Thurberg BL, Depaoli-Roach AA, Roach PJ: Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise. J Biol Chem 280:17260-17265, 2005
17. Kobayashi M, Takatori T, Nakajima M, Saka K, Iwase H, Nagao M, Niijima H, Matsuda Y: Does the sequence of onset of rigor mortis depend on the proportion of muscle fibre types and on intra-muscular glycogen content? Int J Legal Med 112:167-171, 1999
18. Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10, 1999
19. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem 244:1-14, 1997
20. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167, 1988
21. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
22. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Kahn CR, Shulman GI: Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105:1791-1797, 2000
23. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569, 1998
24. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924-928, 2000
25. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI: Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 108:153-160, 2001
26. Wojtaszewski JF, Higaki Y, Hirshman MF, Michael MD, Dufresne SD, Kahn CR, Goodyear LJ: Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 104:1257-1264, 1999
27. Hansen BF, Wojtaszewski JF: Use of transgenic models to understand effects of exercise on glucose metabolism. Exerc Sport Sci Rev 30:53-58, 2002
28. Marshall BA, Mueckler MM: Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267:E738-E744, 1994
29. Liu ML, Gibbs EM, McCoid SC, Milici AJ, Stukenbrok HA, McPherson RK, Treadway JL, Pessin JE: Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc Natl Acad Sci U S A 90:11346-11350, 1993
30. Marshall BA, Ren JM, Johnson DW, Gibbs EM, Lillquist JS, Soeller WC, Holloszy JO, Mueckler M: Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem 268:18442-18445, 1993
31. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, Mueckler M: Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268:16113-16115, 1993
32. Gulve EA, Ren JM, Marshall BA, Gao J, Hansen PA, Holloszy JO, Mueckler M: Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1: increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. J Biol Chem 269:18366-18370, 1994
33. Delibegovic M, Armstrong CG, Dobbie L, Watt PW, Smith AJ, Cohen PT: Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance. Diabetes 52:596-604, 2003
34. Printen JA, Brady MJ, Saltiel AR: PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 275:1475-1478, 1997
35. Crosson SM, Khan A, Printen J, Pessin JE, Saltiel AR: PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest 111:1423-1432, 2003
36. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI: Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456-8460, 2000
37. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI, Mitchell GA, Kim JK: Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol Endocrinol Metab 289:E30-E39, 2005
38. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97, 2000
39. Kasuga M, Ogawa W, Ohara T: Tissue glycogen content and glucose intolerance. J Clin Invest 111:1282-1284, 2003
40. Bergstrom J, Hultman E, Roch-Norlund AE: Muscle glycogen synthetase in normal subjects: basal values, effect of glycogen depletion by exercise and of a carbohydrate-rich diet following exercise. Scand J Clin Lab Invest 29:231-236, 1972
41. Wang Z, Zhu S, Wang J, Pierson RN Jr, Heymsfield SB: Whole-body skeletal muscle mass: development and validation of total-body potassium prediction models. Am J Clin Nutr 77:76-82, 2003
42. Clarys JP, Martin AD, Marfell-Jones MJ, Janssens V, Caboor D, Drinkwater DT: Human body composition: a review of adult dissection data. Am J Human Biol 11:167-174, 1999
43. Ivy JL: Role of carbohydrate in physical activity. Clin Sports Med 18:469-484, 1999
44. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D: AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867- 871, 2003
45. Kahn BB, Alquier T, Carling D, Hardie DG: AMP-activated prtoein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25, 2005
46. Kemp BE: Bateman domains and adenosine derivatives form a binding contract. J Clin Invest 113:182-184, 2004
47. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA: Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284-292, 2002
48. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ: Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high- carbohydrate diets. Proc Natl Acad Sci U S A 100:10207-10212, 2003
49. Cariou B, Postic C, Boudou P, Burcelin R, Kahn CR, Girard J, Burnol AF, Mauvais-Jarvis F: Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 145:1926-1932, 2004
50. Kotani K, Peroni OD, Minokoshi Y, Boss O, Kahn BB: GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest 114:1666-1675, 2004
51. Mauvais-Jarvis F, Virkamaki A, Michael MD, Winnay JN, Zisman A, Kulkarni RN, Kahn CR: A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes 49:2126-2134, 2000
52. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK: Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537:633-639, 2001